FREZTA

Serial Number 78229710
606

Registration Progress

Application Filed
Mar 25, 2003
Under Examination
Feb 10, 2004
Approved for Publication
Oct 29, 2003
Published for Opposition
Nov 18, 2003
Registered

Trademark Image

FREZTA

Basic Information

Serial Number
78229710
Filing Date
March 25, 2003
Published for Opposition
November 18, 2003
Abandonment Date
August 11, 2005
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 11, 2005
Classes
005

Rights Holder

Pharmacia & Upjohn Company

03
Address
100 Route 206 North
Peapack, NJ 07977

Ownership History

Pharmacia & Upjohn Company

Original Applicant
03
Peapack, NJ

Pharmacia & Upjohn Company

Owner at Publication
03
Peapack, NJ

Legal Representation

Attorney
Cynthia B. Summerfield

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

13 events
Date Code Type Description Documents
Oct 11, 2005 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 11, 2005 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 28, 2004 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 28, 2004 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 28, 2004 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 2, 2004 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 13, 2004 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 13, 2004 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 10, 2004 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 18, 2003 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 29, 2003 NPUB O NOTICE OF PUBLICATION Loading...
Sep 9, 2003 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 9, 2003 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely preparations for the treatment of infectious diseases, cancer, ophthalmologic conditions and diseases, central nervous systems diseases and disorders, Parkinson's disease, cardiovascular diseases and conditions, migraines, arthritis, pharmaceutical preparations for the treatment of gastrointestinal diseases, Crohns disease, pharmaceutical preparations for the treatment and symptoms of diabetes, pharmaceutical preparations for urological use, pharmaceutical preparations for the treatment of urinary tract and bladder infections, gynecological preparations for the treatment of birth control, and for the treatment for endometriosis, hormonal preparations, namely hormone replacement therapy; Analgesics; anti-inflammatory pharmaceutical preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005